Stock OPTI OPTIMI HEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Optimi Health Corp.

Equities

OPTI

CA68405H1001

Market Closed - Canadian Securities Exchange
Other stock markets
 20:31:37 14/05/2024 BST 		5-day change 1st Jan Change
0.36 CAD 0.00% Intraday chart for Optimi Health Corp. +2.86% +46.94%
05-09 Optimi Health Corp. Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research CI
04-23 Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules
GL
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules
AQ
Optimi Health Provides Corporate Update
GL
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
GL
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
AQ
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
GL
Early Warning Press Release in Accordance with National Instrument 62-103
NE
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
GL
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
GL
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
AQ
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
GL
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
GL
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
GL
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
AQ
Optimi Announces Non-Brokered Private Placement
GL
Optimi Health To Host MDMA Educational Quality Assurance Webinar For Clinicians And Practitioners
GL
Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
GL
Optimi Health Secures Amendment to Increase Quantities Of MDMA, MDA, And 2C-B Under Controlled Drugs And Substances Dealer’s Licence
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPTI Stock
  4. News Optimi Health Corp.
  5. Press Releases